Evidence map›Paper›PMID 32232203›Full record

ArticleNorthern clinics of Istanbul2020

A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio.

Suleyman Sayar, Kemal Kurbuz, Resul Kahraman, Zuhal Caliskan, Roni Atalay, Oguzhan Ozturk, Hamdi Levent Doganay, Kamil Ozdil

Abstract read
In one paragraph

Article in Northern clinics of Istanbul, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. C-Reactive Protein/Albumin Ratio at Diagnosis of Pediatric Inflammatory Bowel Disease: A Retrospective Multi-Center Study.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  19. Methylation ofGenes · 2022
    Article
  20. Monocyte/High-Density Lipoprotein Ratio Is an Indicator of Activity in Patients with Ulcerative Colitis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suleyman SayarDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Kemal KurbuzDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Resul KahramanDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Zuhal CaliskanDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Roni AtalayDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Oguzhan OzturkDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Hamdi Levent DoganayDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.
Kamil OzdilDepartment of Gastroenterology, Saglık Bilimleri University Umraniye Training and Research Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThere are many instruments to measure disease activity in ulcerative colitis. While determining clinical activity according to these instruments, many clinical and laboratory parameters are needed to be followed. Determination of disease activity with non-invasive and objective inflammatory indicators may be a practical and objective way. CRP/Albumin ratio (CAR) is an inflammatory marker that is considered to have prognostic value in various cancers, sepsis and acute pancreatitis. In this study, we aim to investigate diagnostic performance CAR in determining the clinical severity of ulcerative colitis.

methodsBetween November 2011 and February 2017, hospital records and follow-up cards of patients with ulcerative colitis were reviewed retrospectively. One hundred forty-nine patients were included in this study. Patient's demographic data, laboratory values, clinical disease activity, according to Truelove & Witts criteria and endoscopic activity according to the Mayo sub-score and treatments, were recorded. Diagnostic performance of CAR analyzed to determine the clinical severity.

resultsOf the patients included in this study, 99 (62%) were male, and 50 (38%) were female. Mean age was 45.22±14 years. When patients were grouped into remission, mild, moderate and severe disease according to disease activity, there was a statistically significant difference between CRP, CAR, erythrocyte sedimentation rate (ESR) and albumin levels (p=0.001; p<0.05). Area under the curve (AUC) values for the diagnosis of severe disease were 0.941, 0.931, 0.888 and 0.883 for CAR, CRP, ESR and albumin levels, respectively. Cut-off value to determine severe disease for CAR was 0.6 (sensitivity: 88.9%, specificity of 90.3%, positive predictive value (PPV) 85.1%, negative predictive value (NPV) 92.8%, AUC: 0.941, p<0.001).

conclusionThere was a significant relationship between CAR, CRP, ESR and albumin levels and clinical disease severity in patients with ulcerative colitis. CAR is a cheap and practical marker for the diagnosis of acute severe ulcerative colitis.

Indexed as

AlbuminCRPCRP/albumin ratiodisease activityulcerative colitis

Identifiers

PMID32232203
PMCPMC7103752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.